Andrew A. F. Hack is CFO at Editas Medicine, Inc. (EDIT). They have made 40 open-market trades across 6 companies since 2017, most recently 2026-01-06.
CIK 0001657434
15 open-market purchases totalling $98.6M since 2020, against 25 sales. Across 14 scored buys the stock is up 55.5% at ninety days, and 54.3 points ahead of the S&P over the same stretch.
14 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 29% | 64% | 71% |
| Avg Move | -4.5% | +8.3% | +55.5% |
| Alpha | -4.5% | +10.8% | +54.3% |
| Scored | 14 | 14 | 14 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NUVL | SELL | 2024-12-11 | 2024-12-13 | $88.00 | $110.0M | -5.1% | -16.9% | -13.9% |
| NUVL | SELL | 2024-03-27 | 2024-03-29 | $72.77 | $128.1M | -13.2% | -11.9% | -0.2% |
| DVAX | SELL | 2023-08-08 | 2023-08-10 | $14.39 | $21.6M | +5.3% | -5.1% | -6.4% |
| DVAX | SELL | 2023-06-14 | 2023-06-16 | $12.68 | $6.3M | +1.6% | +9.9% | +9.6% |
| DVAX | SELL | 2023-05-18 | 2023-05-19 | $10.55 | $10.6M | +4.0% | +17.0% | +29.6% |
| DVAX | SELL | 2022-12-06 | 2022-12-08 | $11.60 | $17.4M | -3.4% | -11.2% | -13.9% |
| NUVL | BUY | 2022-11-03 | 2022-11-03 | $33.50 | $10.0M | +6.8% | +11.9% | -5.0% |
| DVAX | SELL | 2022-08-15 | 2022-08-17 | $14.68 | $44.0M | -14.1% | -11.1% | +2.4% |
| MRSN | BUY | 2022-05-31 | 2022-06-02 | $3.27 | $577K | -11.8% | +44.4% | +121.9% |
| MRSN | BUY | 2022-05-24 | 2022-05-26 | $3.21 | $1.1M | +14.0% | +51.6% | +148.4% |
| MRSN | BUY | 2022-05-19 | 2022-05-23 | $3.46 | $800K | -2.6% | +31.6% | +118.1% |
| MRSN | BUY | 2022-05-16 | 2022-05-18 | $3.25 | $2.3M | -0.9% | +9.8% | +114.5% |
| MRSN | BUY | 2022-04-13 | 2022-04-14 | $4.05 | $5.0M | -27.6% | -36.6% | +14.4% |
| MRSN | BUY | 2022-04-12 | 2022-04-13 | $4.18 | $5.0M | -24.0% | -38.9% | +6.1% |
| MRSN | BUY | 2022-02-07 | 2022-02-08 | $4.42 | $10.0M | -18.5% | -7.8% | -33.1% |
| MRSN | BUY | 2021-12-30 | 2022-01-04 | $6.15 | $5.0M | -4.5% | -34.8% | -31.0% |
| MRSN | BUY | 2021-12-29 | 2022-01-03 | $5.75 | $5.0M | -14.1% | -38.9% | -35.2% |
| DVAX | SELL | 2021-08-27 | 2021-08-27 | $16.22 | $64.9M | +8.6% | +6.0% | -6.4% |
| DVAX | SELL | 2021-08-09 | 2021-08-11 | $10.80 | $24.3M | +10.2% | +40.4% | +27.8% |
| NUVL | BUY | 2021-08-02 | 2021-08-04 | $17.00 | $12.5M | -4.7% | +49.1% | +9.2% |
| MRSN] | BUY | 2021-01-08 | 2021-01-12 | $18.36 | $4.6M | N/A | N/A | N/A |
| AVIR | BUY | 2020-11-03 | 2020-11-03 | $24.00 | $6.0M | +15.4% | +0.5% | +170.0% |
| DVAX | BUY | 2020-05-27 | 2020-05-28 | $5.00 | $5.0M | +14.0% | +64.5% | +20.9% |
| MRSN | BUY | 2020-04-07 | 2020-04-09 | $6.27 | $25.6M | -3.8% | +9.6% | +157.9% |
| EDIT | SELL | 2019-02-04 | 2019-02-06 | $21.39 | $295K | -3.5% | +7.9% | +17.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| Total |
| $217.3M |
Shares reported on the most recent Form 4, priced at the 2024-12-13 close. 2 holdings could not be priced and are excluded from the total.